Sun Life Financial INC Has $907,000 Stake in Monsanto Company (MON)
Sun Life Financial INC trimmed its stake in Monsanto Company (NYSE:MON) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,581 shares of the basic materials company’s stock after selling 555 shares during the quarter. Sun Life Financial INC’s holdings in Monsanto were worth $907,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Meyer Handelman Co. raised its holdings in shares of Monsanto by 0.6% in the third quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after acquiring an additional 706 shares during the last quarter. Toronto Dominion Bank grew its position in shares of Monsanto by 6.3% in the third quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock valued at $121,519,000 after purchasing an additional 59,750 shares during the period. Nikko Asset Management Americas Inc. grew its position in shares of Monsanto by 1.3% in the second quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock valued at $53,345,000 after purchasing an additional 5,700 shares during the period. Oakbrook Investments LLC grew its position in shares of Monsanto by 7.4% in the third quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock valued at $2,438,000 after purchasing an additional 1,400 shares during the period. Finally, Aviva PLC grew its position in shares of Monsanto by 1.2% in the second quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock valued at $36,052,000 after purchasing an additional 3,569 shares during the period. 76.00% of the stock is owned by institutional investors.
In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is owned by company insiders.
Monsanto Company (NYSE MON) traded down $0.97 during mid-day trading on Thursday, reaching $117.71. The company’s stock had a trading volume of 3,351,700 shares, compared to its average volume of 1,940,994. Monsanto Company has a 1 year low of $101.56 and a 1 year high of $122.79. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. The stock has a market capitalization of $52,242.94, a P/E ratio of 21.46, a PEG ratio of 1.71 and a beta of 1.05.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the previous year, the business earned $0.07 earnings per share. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. equities analysts predict that Monsanto Company will post 5.74 earnings per share for the current fiscal year.
A number of brokerages have recently commented on MON. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Wells Fargo & Company lifted their price objective on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research report on Tuesday, October 10th. Barclays reaffirmed an “equal weight” rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Finally, Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Monsanto has an average rating of “Hold” and an average price target of $124.61.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.